Tivity Health (NASDAQ:TVTY) and HemaCare (OTCMKTS:HEMA) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, dividends, analyst recommendations, risk, valuation and institutional ownership.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Tivity Health and HemaCare, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tivity Health 0 0 8 0 3.00
HemaCare 0 0 1 0 3.00

Tivity Health currently has a consensus price target of $34.00, suggesting a potential upside of 86.00%. Given Tivity Health’s higher probable upside, equities research analysts plainly believe Tivity Health is more favorable than HemaCare.

Risk & Volatility

Tivity Health has a beta of 1.1, suggesting that its share price is 10% more volatile than the S&P 500. Comparatively, HemaCare has a beta of 1.37, suggesting that its share price is 37% more volatile than the S&P 500.


This table compares Tivity Health and HemaCare’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Tivity Health 12.18% 26.02% 10.82%
HemaCare N/A N/A N/A

Insider and Institutional Ownership

85.4% of Tivity Health shares are held by institutional investors. 1.6% of Tivity Health shares are held by insiders. Comparatively, 26.2% of HemaCare shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Valuation & Earnings

This table compares Tivity Health and HemaCare’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Tivity Health $606.30 million 1.44 $98.80 million $2.34 7.82
HemaCare N/A N/A N/A N/A N/A

Tivity Health has higher revenue and earnings than HemaCare.


Tivity Health beats HemaCare on 7 of the 9 factors compared between the two stocks.

Tivity Health Company Profile

Tivity Health, Inc. provides fitness and health improvement programs in the United States. The company offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement; and Prime fitness, a fitness facility access program through commercial health plans and employers. It also provides health plans through WholeHealth Living program; and health services, such as chiropractic care, acupuncture, physical therapy, occupational therapy, speech therapy, and others. The company was formerly known as Healthways, Inc. and changed its name to Tivity Health, Inc. in January 2017. Tivity Health, Inc. was founded in 1981 and is headquartered in Franklin, Tennessee.

HemaCare Company Profile

HemaCare Corporation provides human-derived primary blood cells and tissues for biomedical research, and supporting cell therapy clinical trials and commercialization with apheresis collections in the United States. The company specializes in the customized collection, isolation, and testing of primary human blood cells and other biological products for research protocols and cellular therapy. It offers human blood cellular components derived from peripheral blood, bone marrow, and cord blood; and a range of consulting services in standard operating procedure development, personnel training, and quality and regulatory compliance. The company's network of FDA-registered, GMP/GTP-compliant collection centers ensures donor materials available to customers, as well as for use within its isolation laboratory. The company has strategic partnership with Charles River Laboratories International Inc. for human immune system research. HemaCare Corporation was founded in 1978 and is headquartered in Northridge, California.

Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.